Stock listing

NASDAQ:NCEL NewcelX Ltd. Stock

Home listing (NASDAQ) of NewcelX Ltd.

Follow NewcelX Ltd. into a list and get an email when it puts out news.

Share price · NASDAQ:NCEL

$2.54 USD -0.11 (-4.2%)

Close on Nov 20, 2026

Past year -19.4% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.45 – $2.63 USDNov 20, 2026
Volume
5,608 sharesNov 20, 2026
Market cap
$14.67M USDAt the close on Nov 20, 2026 · price × 5.78M shares outstanding
52-week range
$1.83 – $5.12 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$36,974 USDMedian day 7,200 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
NewcelX Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:NCEL · Home$2.54 USD-0.11 (-4.2%)5,608$2.63$2.63$2.45$2.65Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:NCEL · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.54-0.11-4.2%$2.63$2.63$2.455,608
$2.65-0.03-1.1%$2.70$2.70$2.644,291
$2.68-0.07-2.5%$2.501$2.68$2.5017,648
$2.75+0.14+5.4%$2.61$2.75$2.616,399
$2.61-0.08-3.0%$2.70$2.70$2.5512,046
$2.69-0.11-3.9%$2.92$2.975$2.6912,215
$2.80-0.06-2.1%$2.95$3.10$2.7329,907
$2.86+0.08+2.9%$2.86$2.892$2.6824,395
$2.78+0.056+2.0%$2.78$2.884$2.6021,353
$2.724-0.166-5.7%$2.80$2.80$2.64511,156
$2.89+0.33+12.9%$2.30$2.90$2.27538,594
$2.56-0.08-3.0%$2.45$2.67$2.34275,030
$2.64+0.15+6.0%$2.40$2.66$2.4019,222
$2.49-0.06-2.4%$2.551$2.57$2.3611,343
$2.55-0.142-5.3%$2.59$2.75$2.5011,157
$2.692-0.008-0.3%$2.70$2.73$2.6481,701
$2.70-0.04-1.5%$2.72$2.80$2.613,864
$2.74+0.19+7.5%$2.59$2.80$2.5912,390
$2.55-0.11-4.1%$2.49$2.84$2.4416,190
$2.66+0.10+3.9%$2.53$2.76$2.4910,400
$2.56-0.39-13.2%$2.97$3.00$2.3612,200
$2.95+0.34+13.0%$2.59$3.04$2.5911,900
$2.61-0.02-0.8%$2.72$3.00$2.559,400
$2.63+0.13+5.2%$2.90$2.90$2.535,400
$2.50-0.35-12.3%$2.77$3.14$2.36123,100
$2.85+0.24+9.2%$2.61$2.90$2.615,900
$2.61-0.23-8.1%$2.80$2.87$2.619,300
$2.84-0.064-2.2%$2.83$3.279$2.805,400
$2.904-0.141-4.6%$2.96$2.96$2.9041,200
$3.045-0.065-2.1%$3.02$3.082$3.021,300
$3.11+0.075+2.5%$2.925$3.11$2.897,300
$3.035+0.074+2.5%$3.04$3.04$2.9751,500
$2.961+0.101+3.5%$2.99$3.20$2.9167,200
$2.86+0.01+0.4%$2.824$2.86$2.824,100
$2.85-0.06-2.1%$2.83$2.871$2.7913,000
$2.91-0.165-5.4%$2.82$2.95$2.765,200
$3.075+0.105+3.5%$3.22$3.25$3.002,700
$2.97+0.05+1.7%$2.85$2.97$2.793,100
$2.92-0.027-0.9%$2.87$3.02$2.767,200
$2.947+0.057+2.0%$2.99$3.21$2.9474,800
$2.89+0.03+1.0%$2.89$2.90$2.764,200
$2.86-0.176-5.8%$2.91$3.09$2.7589,300
$3.036+0.066+2.2%$2.96$3.37$2.904,700
$2.97-0.18-5.7%$3.23$3.243$2.9012,300
$3.15-0.23-6.8%$3.158$3.38$3.132,500
$3.38-0.01-0.3%$3.295$3.39$3.1512,200
$3.39+0.07+2.1%$3.293$3.40$3.144,600
$3.32+0.04+1.2%$3.35$3.35$3.312,800
$3.28-0.025-0.8%$3.28$3.31$3.2256,800
$3.305-0.075-2.2%$3.30$3.324$3.2243,700
$3.38+0.13+4.0%$3.29$3.50$3.255,700
$3.250.000.0%$3.16$3.30$3.163,500
$3.25-0.10-3.0%$3.235$3.35$3.224,200
$3.350.000.0%$3.37$3.37$3.241,400
$3.350.000.0%$3.458$3.50$3.1479,000
$3.35+0.06+1.8%$3.39$3.39$3.333,500
$3.29+0.015+0.5%$3.21$3.29$3.211,900
$3.275+0.085+2.7%$3.40$3.40$3.2313,900
$3.19-0.23-6.7%$3.37$3.37$3.1912,400
$3.42+0.04+1.2%$3.27$3.51$3.2720,000
$3.38-0.10-2.9%$3.44$3.514$3.3018,700
$3.48+0.02+0.6%$3.50$3.60$3.3117,000
$3.46+0.197+6.0%$3.40$3.50$3.3256,100
$3.263-0.107-3.2%$3.31$3.31$3.2151,400
$3.37+0.12+3.7%$3.25$3.40$3.179,200

Splits

2 splits since 2024 · NASDAQ:NCEL · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-40Consolidation
Ticker
NASDAQ:NCEL
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All NewcelX Ltd. news

NewcelX Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 21 in all · newest Nov 9, 2026 · oldest 2025
Decks
9 decks · latest Apr 20, 2026

Where NewcelX Ltd. is listed

ListingExchangeCountryCurrency
NASDAQ:NCEL · Home listing · This pageNASDAQUnited StatesUSD
BOATS:NCELBOATSUnited StatesUSD

Valuation

Price/book 2.4× against a median of 0.7×: 6th lowest of 7 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$14.35M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
Negative EBITDA
Price/book
2.4×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.1×
Beta vs S&P 500
0.89

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
NewcelX Ltd. · NASDAQ:NCELUS$14.67MUS$14.35Mn/an/an/a2.4×n/a0.1×0.89
Quoin Pharmaceuticals. Ltd · NASDAQ:QNRXUS$15.76M−US$17.43Mn/an/an/a0.6×n/a0.0×0.68
Celularity Inc. · NASDAQ:CELUUS$15.02MUS$50.46Mn/a2.7×n/an/a−117.3%n/a1.47
Context Therapeutics Inc. · NASDAQ:CNTXUS$14.70M−US$19.50Mn/an/an/a0.5×n/a0.0×0.99
Hepion Pharmaceuticals, Inc. · OTC:HEPAUS$14.63MUS$10.37Mn/an/an/an/an/an/a-1.02
Vectorite Biomedical, Inc. · TPEX:4170US$14.21MUS$9.16M4.9×4.9×n/a0.9×156.6%0.0×n/a
Estrella Immunopharma, Inc. · NASDAQ:ESLAUS$14.11MUS$14.01Mn/an/an/an/an/an/a1.31
Citius Pharmaceuticals, Inc. · NASDAQ:CTXRUS$13.96M−US$3.05Mn/an/an/a0.2×n/a0.0×1.71
TaiwanJ Pharmaceuticals Co., Ltd. · TPEX:6549US$13.69MUS$11.86Mn/an/an/a7.0×n/a0.0×n/a
Actuate Therapeutics, Inc. · NASDAQ:ACTUUS$13.60MUS$11.50Mn/an/an/an/an/an/a1.75
BeyondSpring, Inc. · NASDAQ:BYSIUS$13.57MUS$12.99M0.3×n/an/a0.9×n/a0.0×1.31
Median of the othersUS$14.16MUS$10.94M2.6×3.8×0.7×19.6%0.0×1.31

Forecasts

1 buy · Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.

Price target
23.00 USD · Analysts' mean
EPS, year to Dec 2026
-1.18 · 1 analyst

Team and board

OfficerRole
Jeremy ShefnerPhD, Chief Medical Officer
Julien BoisdronChief Medical Officer of a Swiss Big Pharma

Events

QuarterResultsShare move
Q3 2025Oct 6, 2025−8.3%
Q2 2025Aug 31, 2025−2.8%
Q1 2025May 16, 2025+6.2%
Q3 2024Oct 18, 2024−8.1%
Q1 2023May 5, 2023+5.4%
Q3 2022Oct 11, 2022−4.6%
Q4 2021Mar 24, 2022+3.7%
Q2 2021Sep 28, 2021−1.2%
Q1 2021May 14, 2021+5.3%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (April 2026)Investor deck27 slidesApr 20, 2026
Investor Presentation (January 2026)Investor deck27 slidesJan 29, 2026
Investor Presentation (November 2025)Investor deck43 slidesNov 3, 2025
NLS Pharmaceutics — Investor Presentation (September 2023)Investor deck49 slidesSep 13, 2023
NLS Pharmaceutics — Corporate Update (July 2023)Corporate update41 slidesJul 20, 2023
NLS Pharmaceutics — Investor Presentation (February 2023)Investor deck33 slidesFeb 1, 2023
NLS Pharmaceutics — Investor Presentation (April 2022)Investor deck30 slidesApr 6, 2022
NLS Pharmaceutics — Investor Presentation (July 2021)Investor deck29 slidesJul 6, 2021
NLS Pharmaceutics — Investor Presentation (April 2021)Investor deck26 slidesApr 6, 2021

Open Decks

Financings

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as NLS Pharmaceutics Ltd. Priced at US$4.15 a unit on Jan 28, 2021.

Price
US$4.15 a unit
Units offered
4,819,277 units
Offering size
US$20 million
Underwriters' option
Up to 722,891 more units
Listing
NLSP on the Nasdaq Capital Market
Underwriters
Maxim Group LLC, Brookline Capital Markets · In the order on the cover
Units delivered
On or about Feb 2, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceDec 18, 2019
Filed publiclyFeb 28, 2020
Amended 5 timesNewest Jan 20, 2021
Shares registered with an exchangeJan 28, 2021
Declared effective by the SECJan 28, 2021
Final prospectus, with the priceFeb 1, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Feb 1, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue0
Research and development1.13M992.0K1.61M8.98M5.92M99.6K897.8K708.5K4.32M
Selling, general and administrative1.35M2.20K3.30M2.74K1.44M
Operating income-2.56M-2.07M-3.02M-15.5M-11.9M-2.30M-4.20M-3.45M-5.77M
Depreciation and amortization55.0K413.0K620.0K11.4K10.1K72.2M311116191
EBITDA-2.51M-1.65M-2.40M-15.5M-11.9M69.9M-4.20M-3.45M-5.77M
Interest expense6.01M45.1K119.9K95.2K48.1K86.8K9921.08K890.4K
Income before tax-8.30M-7.20M-3.28M-2.86M-5.45M-5.15K-6.66M
Income tax-5.77K
Net income-8.30M-7.20M-3.33M-16.5M-11.9M-2.86M-5.45M-5.15M-6.66M
Earnings per share, basic2.162.431.13-33.52-1.00-0.41-0.78-0.32-5.65
Earnings per share, diluted2.162.431.13-33.52-1.00-0.41

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents2.20M650.0K1.15M8.95M5.43M93.7K220.3K6.68K2.18M
Receivables61.2K75.4K36.9K
Inventory-61.2K-9.36K
Current assets3.18M780.0K1.82M9.25M5.72M196.7K381.7K90.2K2.27M
Property, plant and equipment95.0K123.0K6.69K18.1K29.5K
Goodwill1.73M
Total assets11.4M903.0K1.85M9.28M5.76M1.21M696.4K145.6K2.29M
Accounts payable1.92M515.5K4.63M2.37M1.74M4.01M2.51M1.13M565.0K
Current liabilities4.20M8.90M7.92M3.36M2.40M7.20M4.04M2.41M990.0K
Total debt355.0K263.1K842.1K7.09M8.87M
Total liabilities4.20M8.90M10.7M6.00M5.22M10.2M6.87M8.96M10.0M
Shareholders' equity7.25M-8.00M-1.20M111.0K542.4K-8.98M-6.17M-8.81M-7.72M
Shares outstanding4.80M2.96M810.7K32.4M16.2M6.96M6.96M16.2M1.18M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-2.77M-1.07M-3.44M-13.9M-14.9M-729.4K-190.0K-2.73M-5.43M
Capital spending-8.00K-6.00K-6.00K-39.6K-4000
Free cash flow-2.77M-1.07M-3.45M-15.0M-729.4K-190.0K-2.73M-5.43M
Cash from investing1.70M-6.00K103.0K-39.6K225.6K-217.3K
Cash from financing2.63M450.0K2.85M17.4M20.3M503.5K407.5K557.9K6.73M
Change in cash1.55M-666.0K-658.0K3.52M5.34M-126.6K213.6K-2.18M1.30M

Open Financials

Filings

FilingDateTypeFiled with
DNov 18, 2026Other filingsSEC
6-K · Report of a foreign issuerNov 9, 2026Current reportSEC
6-K · Report of a foreign issuerNov 9, 2026Current reportSEC
6-K · Report of a foreign issuerNov 4, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveSep 23, 2026Other filingsSEC
POS AM · Amendment to an effective registrationSep 18, 2026Offer documentSEC
6-K · Report of a foreign issuerSep 18, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveAug 27, 2026Other filingsSEC
DAug 24, 2026Other filingsSEC
F-3 · Registration statementAug 20, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
6-K · Report of a foreign issuerAug 3, 2026Current reportSEC
6-K · Report of a foreign issuerJul 31, 2026Current reportSEC
6-K · Report of a foreign issuerJul 15, 2026Current reportSEC
6-K · Report of a foreign issuerJul 8, 2026Current reportSEC
6-K · Report of a foreign issuerJul 1, 2026Current reportSEC
6-K · Report of a foreign issuerJun 30, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveJun 18, 2026Other filingsSEC
6-K · Report of a foreign issuerJun 15, 2026Current reportSEC
F-3/A · Registration statement, amendedJun 10, 2026Offer documentSEC
6-K · Report of a foreign issuerJun 5, 2026Current reportSEC
6-K · Report of a foreign issuerMay 27, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveMay 18, 2026Other filingsSEC
UPLOAD · Letter from the SECMay 14, 2026Other filingsSEC
CORRESP · Letter to the SECMay 14, 2026Other filingsSEC
DMay 12, 2026Other filingsSEC
F-3 · Registration statementMay 11, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 7, 2026Other filingsSEC
POS AM · Amendment to an effective registrationMay 5, 2026Offer documentSEC
SCHEDULE 13D · Big-stake noticeMay 4, 2026Big-stake noticeSEC
6-K · Report of a foreign issuerApr 30, 2026Current reportSEC
20-F · Annual reportApr 29, 2026Annual reportSEC
4 · Change in ownershipApr 29, 2026Insider tradeSEC
4 · Change in ownershipApr 29, 2026Insider tradeSEC
6-K · Report of a foreign issuerApr 20, 2026Current reportSEC
6-K · Report of a foreign issuerApr 1, 2026Current reportSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 18, 2026Insider tradeSEC
6-K · Report of a foreign issuerMar 9, 2026Current reportSEC
6-K · Report of a foreign issuerFeb 12, 2026Current reportSEC
6-K · Report of a foreign issuerJan 29, 2026Current reportSEC
6-K · Report of a foreign issuerJan 12, 2026Current reportSEC
6-K · Report of a foreign issuerJan 5, 2026Current reportSEC
6-K · Report of a foreign issuerDec 11, 2025Current reportSEC
6-K · Report of a foreign issuerNov 20, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveNov 19, 2025Other filingsSEC
EFFECT · Notice that a registration is effectiveNov 19, 2025Other filingsSEC
6-K · Report of a foreign issuerNov 17, 2025Current reportSEC
SCHEDULE 13D · Big-stake noticeNov 14, 2025Big-stake noticeSEC
SCHEDULE 13D · Big-stake noticeNov 13, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 13, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 7, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerNov 7, 2025Current reportSEC
POS AM · Amendment to an effective registrationNov 5, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 4, 2025Big-stake noticeSEC
6-K · Report of a foreign issuerNov 4, 2025Current reportSEC
6-K · Report of a foreign issuerNov 3, 2025Current reportSEC
25-NSE/AOct 30, 2025Other filingsSEC
6-K · Report of a foreign issuerOct 30, 2025Current reportSEC
6-K · Report of a foreign issuerOct 30, 2025Current reportSEC
6-K · Report of a foreign issuerOct 29, 2025Current reportSEC
6-K · Report of a foreign issuerOct 28, 2025Current reportSEC
6-K · Report of a foreign issuerOct 28, 2025Current reportSEC
6-K · Report of a foreign issuerOct 27, 2025Current reportSEC
POS AM · Amendment to an effective registrationOct 24, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 23, 2025Current reportSEC
POS AM · Amendment to an effective registrationOct 17, 2025Offer documentSEC
6-K · Report of a foreign issuerOct 9, 2025Current reportSEC
6-K · Report of a foreign issuerOct 3, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveOct 1, 2025Other filingsSEC
6-K · Report of a foreign issuerSep 30, 2025Current reportSEC
CORRESP · Letter to the SECSep 29, 2025Other filingsSEC
UPLOAD · Letter from the SECSep 29, 2025Other filingsSEC
F-1 · Registration statementSep 25, 2025Offer documentSEC
6-K · Report of a foreign issuerSep 19, 2025Current reportSEC
424B3 · ProspectusSep 10, 2025Offer documentSEC
6-K · Report of a foreign issuerSep 10, 2025Current reportSEC
EFFECT · Notice that a registration is effectiveSep 10, 2025Other filingsSEC
CORRESP · Letter to the SECSep 8, 2025Other filingsSEC
425Sep 4, 2025Other filingsSEC
6-K · Report of a foreign issuerSep 4, 2025Current reportSEC
CORRESP · Letter to the SECSep 3, 2025Other filingsSEC
F-4/ASep 3, 2025Offer documentSEC
425Aug 29, 2025Other filingsSEC
6-K · Report of a foreign issuerAug 29, 2025Current reportSEC
UPLOAD · Letter from the SECAug 28, 2025Other filingsSEC
6-K · Report of a foreign issuerAug 25, 2025Current reportSEC
CORRESP · Letter to the SECAug 15, 2025Other filingsSEC
UPLOAD · Letter from the SECAug 6, 2025Other filingsSEC
6-K · Report of a foreign issuerAug 6, 2025Current reportSEC
F-4/AJul 29, 2025Offer documentSEC
CORRESP · Letter to the SECJul 29, 2025Other filingsSEC
UPLOAD · Letter from the SECJul 23, 2025Other filingsSEC
F-4/AJul 18, 2025Offer documentSEC
425Jul 18, 2025Other filingsSEC
6-K · Report of a foreign issuerJul 18, 2025Current reportSEC
6-K · Report of a foreign issuerJul 17, 2025Current reportSEC
DJul 10, 2025Other filingsSEC
6-K · Report of a foreign issuerJul 1, 2025Current reportSEC
425Jul 1, 2025Other filingsSEC
6-K · Report of a foreign issuerJul 1, 2025Current reportSEC
6-K · Report of a foreign issuerJun 30, 2025Current reportSEC
SCHEDULE 13D · Big-stake noticeJun 24, 2025Big-stake noticeSEC
CORRESP · Letter to the SECJun 23, 2025Other filingsSEC
F-4/AJun 23, 2025Offer documentSEC
UPLOAD · Letter from the SECJun 18, 2025Other filingsSEC
425Jun 16, 2025Other filingsSEC
6-K · Report of a foreign issuerJun 16, 2025Current reportSEC
6-K · Report of a foreign issuerJun 10, 2025Current reportSEC
CORRESP · Letter to the SECJun 9, 2025Other filingsSEC
F-4/AJun 9, 2025Offer documentSEC
CORRESP · Letter to the SECJun 9, 2025Other filingsSEC
425Jun 6, 2025Other filingsSEC
6-K · Report of a foreign issuerJun 6, 2025Current reportSEC
20-F · Annual reportMay 16, 2025Annual reportSEC
6-K · Report of a foreign issuerMay 5, 2025Current reportSEC
NT 20-FMay 1, 2025Explanation requestSEC
6-K · Report of a foreign issuerApr 24, 2025Current reportSEC
UPLOAD · Letter from the SECApr 15, 2025Other filingsSEC
425Apr 15, 2025Other filingsSEC
6-K · Report of a foreign issuerApr 15, 2025Current reportSEC
DApr 14, 2025Other filingsSEC
6-K/A · Report of a foreign issuer, amendedApr 4, 2025Current reportSEC
CORRESP · Letter to the SECMar 31, 2025Other filingsSEC
F-4/AMar 31, 2025Offer documentSEC
425Mar 31, 2025Other filingsSEC
6-K · Report of a foreign issuerMar 31, 2025Current reportSEC
UPLOAD · Letter from the SECMar 20, 2025Other filingsSEC
425Mar 10, 2025Other filingsSEC
6-K · Report of a foreign issuerMar 10, 2025Current reportSEC
F-4/AMar 3, 2025Offer documentSEC
CORRESP · Letter to the SECFeb 28, 2025Other filingsSEC
6-K · Report of a foreign issuerFeb 27, 2025Current reportSEC
425Feb 25, 2025Other filingsSEC
6-K · Report of a foreign issuerFeb 25, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
F-3 · Registration statementFeb 10, 2025Offer documentSEC
425Feb 10, 2025Other filingsSEC
6-K · Report of a foreign issuerFeb 10, 2025Current reportSEC
F-3 · Registration statementFeb 5, 2025Offer documentSEC
6-K · Report of a foreign issuerJan 31, 2025Current reportSEC
425Jan 31, 2025Other filingsSEC
6-K · Report of a foreign issuerJan 31, 2025Current reportSEC
6-K · Report of a foreign issuerJan 30, 2025Current reportSEC
425Jan 28, 2025Other filingsSEC
6-K · Report of a foreign issuerJan 28, 2025Current reportSEC
UPLOAD · Letter from the SECJan 27, 2025Other filingsSEC
DJan 22, 2025Other filingsSEC
425Jan 16, 2025Other filingsSEC
6-K · Report of a foreign issuerJan 16, 2025Current reportSEC
6-K · Report of a foreign issuerJan 14, 2025Current reportSEC
425Jan 8, 2025Other filingsSEC
6-K · Report of a foreign issuerJan 8, 2025Current reportSEC
6-K · Report of a foreign issuerJan 7, 2025Current reportSEC
425Dec 30, 2024Other filingsSEC
6-K · Report of a foreign issuerDec 30, 2024Current reportSEC
F-4Dec 30, 2024Offer documentSEC
6-K · Report of a foreign issuerDec 23, 2024Current reportSEC
6-K/A · Report of a foreign issuer, amendedDec 19, 2024Current reportSEC
425Dec 19, 2024Other filingsSEC
6-K · Report of a foreign issuerDec 19, 2024Current reportSEC
6-K · Report of a foreign issuerDec 17, 2024Current reportSEC
425Dec 11, 2024Other filingsSEC
6-K · Report of a foreign issuerDec 11, 2024Current reportSEC
6-K/A · Report of a foreign issuer, amendedDec 10, 2024Current reportSEC
6-K · Report of a foreign issuerDec 4, 2024Current reportSEC
6-K · Report of a foreign issuerDec 3, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveNov 27, 2024Other filingsSEC
CORRESP · Letter to the SECNov 25, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedNov 21, 2024Big-stake noticeSEC
CORRESP · Letter to the SECNov 18, 2024Other filingsSEC
F-3/A · Registration statement, amendedNov 18, 2024Offer documentSEC
6-K · Report of a foreign issuerNov 18, 2024Current reportSEC
6-K · Report of a foreign issuerNov 15, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerNov 12, 2024Current reportSEC
6-K · Report of a foreign issuerNov 8, 2024Current reportSEC
6-K · Report of a foreign issuerNov 6, 2024Current reportSEC
425Nov 5, 2024Other filingsSEC
6-K · Report of a foreign issuerNov 5, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 4, 2024Big-stake noticeSEC
425Nov 4, 2024Other filingsSEC
6-K · Report of a foreign issuerNov 4, 2024Current reportSEC
UPLOAD · Letter from the SECNov 1, 2024Other filingsSEC
6-K · Report of a foreign issuerOct 28, 2024Current reportSEC
F-3 · Registration statementOct 23, 2024Offer documentSEC
6-K · Report of a foreign issuerOct 22, 2024Current reportSEC
DOct 21, 2024Other filingsSEC
6-K · Report of a foreign issuerOct 18, 2024Current reportSEC
SC 13G · Big-stake noticeOct 15, 2024Big-stake noticeSEC
6-K · Report of a foreign issuerOct 15, 2024Current reportSEC
6-K · Report of a foreign issuerOct 11, 2024Current reportSEC

This page holds 200 of 420 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from NewcelX Ltd.’s releases · as of Apr 30, 2026

Common shares
5,776,128
Fully diluted
5,776,128

Fully diluted

LineShares
Common shares5,776,128

Share count over time

CountShares
Nov 22, 20265,776,128

Open Cap table

Shareholders

TradeTradeSharesPriceValueDate
Revel Michel
Director, Officer: CSO and Director, 10% owner
Buy54,545USD 2.75US$150KApr 27, 2026
Samuel Olivier
Director
Buy81,818USD 2.75US$225KApr 27, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Alexander ZwyerDirector · Since at least Mar 18, 2026
Eran Israel IohanDirector · Since at least Mar 18, 2026
Jeremy ShefnerPhD, Chief Medical Officer · Since at least Nov 17, 2025
Julien BoisdronChief Medical Officer of a Swiss Big Pharma · Since at least Apr 30, 2026
Kfir MolakandovVP of R&D · Since at least Mar 18, 2026
Liora OrenDirector · Since at least Mar 18, 2026
Michel RevelCSO and Director, Director · Since at least Mar 18, 2026
Olivier SamuelDirector · Since at least Mar 18, 2026
Omri HagaiChief Financial Officer · Since at least Mar 18, 2026
Ronen TwitoChairman and CEO, Director · Since at least Mar 18, 2026
All 11 people
PersonSeat
Tamar GaliliDirector · Since at least Mar 18, 2026

Open People

Log in to ask 6ix AI your own questions about NewcelX Ltd.